Literature DB >> 26377633

Brain endothelial dysfunction in cerebral adrenoleukodystrophy.

Patricia L Musolino1, Yi Gong1, Juliet M T Snyder2, Sandra Jimenez2, Josephine Lok3, Eng H Lo3, Ann B Moser4, Eric F Grabowski5, Matthew P Frosch6, Florian S Eichler7.   

Abstract

See Aubourg (doi:10.1093/awv271) for a scientific commentary on this article.X-linked adrenoleukodystrophy is caused by mutations in the ABCD1 gene leading to accumulation of very long chain fatty acids. Its most severe neurological manifestation is cerebral adrenoleukodystrophy. Here we demonstrate that progressive inflammatory demyelination in cerebral adrenoleukodystrophy coincides with blood-brain barrier dysfunction, increased MMP9 expression, and changes in endothelial tight junction proteins as well as adhesion molecules. ABCD1, but not its closest homologue ABCD2, is highly expressed in human brain microvascular endothelial cells, far exceeding its expression in the systemic vasculature. Silencing of ABCD1 in human brain microvascular endothelial cells causes accumulation of very long chain fatty acids, but much later than the immediate upregulation of adhesion molecules and decrease in tight junction proteins. This results in greater adhesion and transmigration of monocytes across the endothelium. PCR-array screening of human brain microvascular endothelial cells after ABCD1 silencing revealed downregulation of both mRNA and protein levels of the transcription factor c-MYC (encoded by MYC). Interestingly, MYC silencing mimicked the effects of ABCD1 silencing on CLDN5 and ICAM1 without decreasing the levels of ABCD1 protein itself. Together, these data demonstrate that ABCD1 deficiency induces significant alterations in brain endothelium via c-MYC and may thereby contribute to the increased trafficking of leucocytes across the blood-brain barrier as seen in cerebral adrenouleukodystrophy.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood–brain barrier; demyelination; genetics; leukodystrophy; neurodegeneration; neuroinflammation

Mesh:

Substances:

Year:  2015        PMID: 26377633      PMCID: PMC4731416          DOI: 10.1093/brain/awv250

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  67 in total

Review 1.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

Review 2.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool.

Authors:  Bahareh Ajami; Jami L Bennett; Charles Krieger; Kelly M McNagny; Fabio M V Rossi
Journal:  Nat Neurosci       Date:  2011-07-31       Impact factor: 24.884

Review 4.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

5.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

6.  Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes.

Authors:  F Shimizu; Y Sano; H Haruki; T Kanda
Journal:  Diabetologia       Date:  2011-03-16       Impact factor: 10.122

Review 7.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  Head trauma can initiate the onset of adreno-leukodystrophy.

Authors:  Gerald V Raymond; Roberta Seidman; Teshamae S Monteith; Edwin Kolodny; Swati Sathe; Asif Mahmood; James M Powers
Journal:  J Neurol Sci       Date:  2009-11-28       Impact factor: 3.181

9.  Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.

Authors:  Walter C Hubbard; Ann B Moser; Anita C Liu; Richard O Jones; Steven J Steinberg; Fred Lorey; Susan R Panny; Robert F Vogt; Daniela Macaya; Coleman T Turgeon; Silvia Tortorelli; Gerald V Raymond
Journal:  Mol Genet Metab       Date:  2009-04-01       Impact factor: 4.797

10.  Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.

Authors:  Taura L Barr; Lawrence L Latour; Kyung-Yul Lee; Timothy J Schaewe; Marie Luby; George S Chang; Ziad El-Zammar; Shaista Alam; John M Hallenbeck; Chelsea S Kidwell; Steven Warach
Journal:  Stroke       Date:  2009-12-24       Impact factor: 7.914

View more
  26 in total

1.  A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.

Authors:  Lauren R Strachan; Tamara J Stevenson; Briana Freshner; Matthew D Keefe; D Miranda Bowles; Joshua L Bonkowsky
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

2.  Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?

Authors:  Keith Van Haren; Marc Engelen
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

3.  ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells.

Authors:  Hu Zhang; Shuhong Zhang; Jilin Zhang; Dongxin Liu; Jiayi Wei; Wengang Fang; Weidong Zhao; Yuhua Chen; Deshu Shang
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-21       Impact factor: 6.200

Review 4.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

Review 5.  Repurposing Vorinostat for the Treatment of Disorders Affecting Brain.

Authors:  K V Athira; Prashant Sadanandan; Sumana Chakravarty
Journal:  Neuromolecular Med       Date:  2021-05-04       Impact factor: 3.843

6.  Pathology of the neurovascular unit in leukodystrophies.

Authors:  Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol Commun       Date:  2021-06-03       Impact factor: 7.801

7.  Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.

Authors:  Ann B Moser; Yanqiu Liu; Xiaohai Shi; Ulrike Schrifl; Shandi Hiebler; Ali Fatemi; Nancy E Braverman; Steven J Steinberg; Paul A Watkins
Journal:  J Cell Biochem       Date:  2021-05-30       Impact factor: 4.480

8.  MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy.

Authors:  Afonso P Liberato; Eric J Mallack; Razina Aziz-Bose; Doug Hayden; Arne Lauer; Paul A Caruso; Patricia L Musolino; Florian S Eichler
Journal:  Neurology       Date:  2019-03-22       Impact factor: 11.800

Review 9.  Peroxisomes in brain development and function.

Authors:  Johannes Berger; Fabian Dorninger; Sonja Forss-Petter; Markus Kunze
Journal:  Biochim Biophys Acta       Date:  2015-12-11

Review 10.  Inherited and acquired disorders of myelin: The underlying myelin pathology.

Authors:  Ian D Duncan; Abigail B Radcliff
Journal:  Exp Neurol       Date:  2016-04-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.